Financial Engines Advisors L.L.C.
Source: SEC Form 13F · as of Mar 2026Financial Engines Advisors L.L.C. holds 19 biotech & pharma companies tracked by BioSniper, totaling $35.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$35.6M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 71,800 | $15.6M |
| JNJJOHNSON & JOHNSON | 12,030 | $2.9M |
| LLYELI LILLY & Co | 2,653 | $2.4M |
| ABTABBOTT LABORATORIES | 23,405 | $2.4M |
| DVADaVita Inc. | 14,233 | $2.2M |
| AMGNAMGEN INC | 4,274 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,396 | $1.5M |
| NVSNovartis AG | 6,772 | $1.0M |
| MRKMerck & Co., Inc. | 8,345 | $1.0M |
| CLPTClearPoint Neuro Inc. | 105,033 | $956K |
| GMOptec International, Inc. | 11,418 | $851K |
| PMPhilip Morris International Inc | 4,451 | $736K |
| PFEPFIZER INC | 19,727 | $554K |
| VKTXViking Therapeutics, Inc. | 15,661 | $510K |
| GILDGILEAD SCIENCES, INC. | 3,608 | $503K |
| AQSTAquestive Therapeutics, Inc. | 97,483 | $405K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 621 | $277K |
| ZTSZoetis Inc. | 1,902 | $225K |
| FATEFATE THERAPEUTICS INC | 10,992 | $13K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.